-+ 0.00%
-+ 0.00%
-+ 0.00%

UK life sciences property demand remains resilient as development slows, Pioneer Group says

PUBT·11/18/2026 10:53:56
Listen to the news
UK life sciences property demand remains resilient as development slows, Pioneer Group says
  • Slower UK life sciences property development may not indicate weaker demand, with investment opportunities favoring well-located, high-quality laboratories over speculative space.
  • Golden Triangle laboratory construction totaled 2,900,000 square feet at end-Q2 2026, the lowest since Q1 2024.
  • Almost 800,000 square feet was under offer, suggesting potential for stronger leasing in the second half of 2026.
  • UK life sciences venture funding exceeded £2 billion during the quarter, dominated by Isomorphic Labs' £1.6 billion Series B.
  • Excluding that round, UK biotech funding reached £498 million, up almost 80% from Q2 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pioneer Group published the original content used to generate this news brief on November 18, 2026, and is solely responsible for the information contained therein.